Najat Khan, CEO of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $727.9K. The latest trade was on 06/05.

NK

NK

Najat Khan

CEO and President

Company

Recursion Pharmaceuticals RXRX

First filing

24/08/05

Trades

20 trades

Buys / sales

0 / 4

12-month net buying

−$727.9K

Last trade

06/05

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	06/05	06/05	23,588 sh	$3.58	$84,445.04	−1.1%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	03/09	03/11	28,298 sh	$3.35	$94,798.3	−1.2%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/12/22	25/12/29	124,403 sh	$4.41	$548,617.23	−16.9%
Recursion PharmaceuticalsRXRX	Open-market sale	25/08/18	25/08/19	36,599 sh	$5.52	$202,026.48	−5.2%